Cancer-killing, decoy-resistant interleukin-18.

Kyohei Nakamura Tobias Bald Mark J Smyth

Published in: Immunology and cell biology (2020)

A recent paper by Zhou et al. describes a new engineered decoy-resistant interleukin-18 with potent antitumor activity and translational potential for cancer immunotherapy.

Keyphrases

papillary thyroid
squamous cell
squamous cell carcinoma
human health
childhood cancer
young adults